Clinical Trial Update: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) [Phase 4]

View source ↗

Summary

This Phase 4 trial (PROVE-DM) compares low-intensity statin plus ezetimibe versus high-intensity statin therapy to assess the risk of new-onset diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Diabetes Mellitus
• Prediabetes

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• High-intensity statin therapy (statin (high-intensity))
• Low-intensity statin therapy (statin)

Snippet

Sponsor: Seung-Whan Lee, M.D., Ph.D. | Conditions: Pre Diabetes, ASCVD | Phase 4 | Status: ENROLLING_BY_INVITATION